Stem Cells Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Published Date : Nov 2020 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Stem Cells Market, By Product

7.1.  Stem Cells Market, by Product Type, 2020-2030

7.1.1.    Adult Stem Cells (ASCs)

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Human Embryonic Stem Cells (HESCs)

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Induced Pluripotent Stem Cells (iPSCs)

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Very Small Embryonic Like Stem Cells

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Stem Cells Market, By Application

8.1.  Stem Cells Market, By Application, 2020-2030

8.1.1.    Regenerative Medicine

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Drug Discovery and Development

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Stem Cells Market, By Technology Type

9.1.  Stem Cells Market, By Technology Type, 2020-2030

9.1.1.    Cell Acquisition

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Cell Production

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cryopreservation

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Expansion and Sub-Culture

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Stem Cells Market, By Therapy Type

10.1.        Stem Cells Market, By Therapy Type, 2020-2030

10.1.1.  Autologous

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Allogenic

10.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Stem Cells Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2030)

11.1.2.  Market Revenue and Forecast, By Application (2016-2030)

11.1.3.  Market Revenue and Forecast, By Technology Type (2016-2030)

11.1.4.  Market Revenue and Forecast, By Therapy Type (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.2.      Market Revenue and Forecast, By Application (2016-2030)

11.1.5.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.2.      Market Revenue and Forecast, By Application (2016-2030)

11.1.6.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2030)

11.2.2.  Market Revenue and Forecast, By Application (2016-2030)

11.2.3.  Market Revenue and Forecast, By Technology Type (2016-2030)

11.2.4.  Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.2.      Market Revenue and Forecast, By Application (2016-2030)

11.2.5.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.2.      Market Revenue and Forecast, By Application (2016-2030)

11.2.6.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.2.      Market Revenue and Forecast, By Application (2016-2030)

11.2.7.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.2.      Market Revenue and Forecast, By Application (2016-2030)

11.2.8.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2030)

11.3.2.  Market Revenue and Forecast, By Application (2016-2030)

11.3.3.  Market Revenue and Forecast, By Technology Type (2016-2030)

11.3.4.  Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.2.      Market Revenue and Forecast, By Application (2016-2030)

11.3.5.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.2.      Market Revenue and Forecast, By Application (2016-2030)

11.3.6.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.2.      Market Revenue and Forecast, By Application (2016-2030)

11.3.7.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.2.      Market Revenue and Forecast, By Application (2016-2030)

11.3.8.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2030)

11.4.2.  Market Revenue and Forecast, By Application (2016-2030)

11.4.3.  Market Revenue and Forecast, By Technology Type (2016-2030)

11.4.4.  Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.2.      Market Revenue and Forecast, By Application (2016-2030)

11.4.5.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.2.      Market Revenue and Forecast, By Application (2016-2030)

11.4.6.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.2.      Market Revenue and Forecast, By Application (2016-2030)

11.4.7.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.2.      Market Revenue and Forecast, By Application (2016-2030)

11.4.8.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2030)

11.5.2.  Market Revenue and Forecast, By Application (2016-2030)

11.5.3.  Market Revenue and Forecast, By Technology Type (2016-2030)

11.5.4.  Market Revenue and Forecast, By Therapy Type (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.2.      Market Revenue and Forecast, By Application (2016-2030)

11.5.5.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.2.      Market Revenue and Forecast, By Application (2016-2030)

11.5.6.3.      Market Revenue and Forecast, By Technology Type (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By Therapy Type (2016-2030)

Chapter 12.  Company Profiles

12.1.              CELGENE CORPORATION

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              ReNeuron Group plc

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Virgin Health Bank

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Biovault family

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Precious Cells International Ltd

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Mesoblast Ltd

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Caladrius

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Seneca Biopharmaceuticals, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Opexa Therapeutics, Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           STEMCELL Technologies Inc.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Pluristem Therapeutics Inc

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.12.           ThermoGenesis Holdings, Inc

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.13.           Astellas Pharma Inc.

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.14.           Cellular Engineering Technologies

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.15.           BioTime, Inc.

12.15.1.               Company Overview

12.15.2.               Product Offerings

12.15.3.               Financial Performance

12.15.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Audiology Devices Market (By Product: Hearing Aids, Cochlear Implants; By Technology: Digital, Analog; By Sales Channel: Retail, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Micro-pumps Market (By Product: Mechanical, Non-mechanical; By Application: Drug Delivery, Medical Devices; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    U.S. Behavioral Health Care Software And Services Market (By Component: Software, Support Services; By Delivery Model; By Function; By End Use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Medical Imaging Market (By Product: X-ray, CT, MRI, Ultrasound; By End-use: Hospitals, Diagnostic Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Medical Imaging Phantoms Market (By Device Type: X-ray, Ultrasound, CT, MRI; By End Use; By Material: Simulating Organs, False Organs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...